Alcohol Abuse

>

Latest News

depression
BLP-003 for Treatment-Resistant Depression: Phase 2b Patient Enrollment Completed

March 5th 2025

BLP-003, currently being evaluated for treatment-resistant depression and alcohol use disorder, today announced their global phase 2b clinical trial has completed patient enrollment.

FDA
Positive FDA Feedback for Proposed In Vitro Bridging Strategy for Alcohol Use Disorder Treatment, AD04

February 25th 2025

addiction
Patent Issued for Methods of Identifying Patients With Substance Use-Associated Genetic Markers, Treatment With AD04

February 12th 2025

alcohol
Alcohol: Friend and Foe

February 10th 2025

pipeline
January in Review: Updates on the Psychiatric Treatment Pipeline

January 31st 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.